Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy

Mutations in the CNGB3 gene account for >50% of all known cases of achromatopsia. Although of early onset, its stationary character and the potential for rapid assessment of restoration of retinal function following therapy renders achromatopsia a very attractive candidate for gene therapy. Here we tested the efficacy of an rAAV2/8 vector containing a human cone arrestin promoter and a human CNGB3 cDNA in CNGB3 deficient mice. Following subretinal delivery of the vector, CNGB3 was detected in both M- and S-cones and resulted in increased levels of CNGA3, increased cone density and survival, improved cone outer segment structure and normal subcellular compartmentalization of cone opsins. Therapy also resulted in long-term improvement of retinal function, with restoration of cone ERG amplitudes of up to 90% of wild-type and a significant improvement in visual acuity. Remarkably, successful restoration of cone function was observed even when treatment was initiated at 6 months of age; however, restoration of normal visual acuity was only possible in younger animals (e.g. 2–4 weeks old). This study represents achievement of the most substantial restoration of visual function reported to date in an animal model of achromatopsia using a human gene construct, which has the potential to be utilized in clinical trials.

[1]  Jianhua Xu,et al.  Early-onset, slow progression of cone photoreceptor dysfunction and degeneration in CNG channel subunit CNGB3 deficiency. , 2011, Investigative ophthalmology & visual science.

[2]  Mervyn G. Thomas,et al.  High-resolution in vivo imaging in achromatopsia. , 2011, Ophthalmology.

[3]  C. Klaver,et al.  Progressive loss of cones in achromatopsia: an imaging study using spectral-domain optical coherence tomography. , 2010, Investigative ophthalmology & visual science.

[4]  N. Tanimoto,et al.  Restoration of cone vision in the CNGA3-/- mouse model of congenital complete lack of cone photoreceptor function. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  András M Komáromy,et al.  Gene therapy rescues cone function in congenital achromatopsia. , 2010, Human molecular genetics.

[6]  W. Hauswirth,et al.  Functional and Behavioral Restoration of Vision by Gene Therapy in the Guanylate Cyclase-1 (GC1) Knockout Mouse , 2010, PloS one.

[7]  R. Barlow,et al.  Impaired cone function and cone degeneration resulting from CNGB3 deficiency: down-regulation of CNGA3 biosynthesis as a potential mechanism. , 2009, Human molecular genetics.

[8]  Jay Neitz,et al.  Gene therapy for red-green colour blindness in adult primates , 2009, Nature.

[9]  Mark Basche,et al.  Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. , 2009, Human molecular genetics.

[10]  C. Klaver,et al.  Genetic etiology and clinical consequences of complete and incomplete achromatopsia. , 2009, Ophthalmology.

[11]  G. Fain,et al.  Knockout of GARPs and the β-subunit of the rod cGMP-gated channel disrupts disk morphogenesis and rod outer segment structural integrity , 2009, Journal of Cell Science.

[12]  Shannon M. Conley,et al.  Differential requirements for retinal degeneration slow intermolecular disulfide-linked oligomerization in rods versus cones. , 2009, Human molecular genetics.

[13]  P. Dolph,et al.  Accumulation of Rhodopsin in Late Endosomes Triggers Photoreceptor Cell Degeneration , 2009, PLoS genetics.

[14]  David Williams,et al.  In vivo imaging of the photoreceptor mosaic of a rod monochromat , 2008, Vision Research.

[15]  Edwin M Stone,et al.  Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics , 2008, Proceedings of the National Academy of Sciences.

[16]  J. Fitzgerald,et al.  Native cone photoreceptor cyclic nucleotide‐gated channel is a heterotetrameric complex comprising both CNGA3 and CNGB3: a study using the cone‐dominant retina of Nrl−/− mice , 2008, Journal of neurochemistry.

[17]  Kathleen A. Marshall,et al.  Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[18]  Nick Tyler,et al.  Effect of gene therapy on visual function in Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[19]  K. Koeppen,et al.  Functional analysis of human CNGA3 mutations associated with colour blindness suggests impaired surface expression of channel mutants A3R427C and A3R563C , 2008, The European journal of neuroscience.

[20]  S. E. Barker,et al.  Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8 , 2008, Gene Therapy.

[21]  M. Elliott,et al.  Functional activity of photoreceptor cyclic nucleotide-gated channels is dependent on the integrity of cholesterol- and sphingolipid-enriched membrane domains. , 2008, Biochemistry.

[22]  Yumiko Umino,et al.  Speed, Spatial, and Temporal Tuning of Rod and Cone Vision in Mouse , 2008, The Journal of Neuroscience.

[23]  G. H. Jacobs,et al.  Response to Comment on "Emergence of Novel Color Vision in Mice Engineered to Express a Human Cone Photopigment" , 2007, Science.

[24]  C. Mussolino,et al.  Novel Adeno-Associated Virus Serotypes Efficiently Transduce Murine Photoreceptors , 2007, Journal of Virology.

[25]  W. Hauswirth,et al.  Restoration of cone vision in a mouse model of achromatopsia , 2007, Nature Medicine.

[26]  J. Lupski,et al.  Achromatopsia: the CNGB3 p.T383fsX mutation results from a founder effect and is responsible for the visual phenotype in the original report of uniparental disomy 14 , 2007, Human Genetics.

[27]  Muna I. Naash,et al.  Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles , 2006, PloS one.

[28]  W. Hauswirth,et al.  Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  R M Douglas,et al.  Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system , 2005, Visual Neuroscience.

[30]  M. Sandberg,et al.  Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP. , 2005, Investigative ophthalmology & visual science.

[31]  S. Haverkamp,et al.  Impaired opsin targeting and cone photoreceptor migration in the retina of mice lacking the cyclic nucleotide-gated channel CNGA3. , 2005, Investigative ophthalmology & visual science.

[32]  M. Sandberg,et al.  Cone cGMP‐gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases , 2005, Human mutation.

[33]  P. Sieving,et al.  CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia , 2005, European Journal of Human Genetics.

[34]  J. Gray,et al.  Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. , 2004, Journal of virological methods.

[35]  M. Naash,et al.  The R172W mutation in peripherin/rds causes a cone-rod dystrophy in transgenic mice. , 2004, Human molecular genetics.

[36]  R. Bernabeu,et al.  Cellular Processing of Cone Photoreceptor Cyclic GMP-gated Ion Channels , 2004, Journal of Biological Chemistry.

[37]  J. Mollon,et al.  Achromatopsia caused by novel mutations in both CNGA3 and CNGB3 , 2004, Journal of Medical Genetics.

[38]  M. Varnum,et al.  Achromatopsia-associated Mutation in the Human Cone Photoreceptor Cyclic Nucleotide-gated Channel CNGB3 Subunit Alters the Ligand Sensitivity and Pore Properties of Heteromeric Channels* , 2003, Journal of Biological Chemistry.

[39]  R. Ali,et al.  AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  A. Swaroop,et al.  Transgenic Mice Lines Expressing Cre-Recombinase Specifically in the Photoreceptors or Retinal Pigment Epithelium: Towards Somatic Mutagenesis in Retinal Cell Types , 2003 .

[41]  Lili Wang,et al.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Kotin,et al.  Virus-Mediated Transduction of Murine Retina with Adeno-Associated Virus: Effects of Viral Capsid and Genome Size , 2002, Journal of Virology.

[43]  C. Craft,et al.  Retinoic acid upregulates cone arrestin expression in retinoblastoma cells through a Cis element in the distal promoter region. , 2002, Investigative ophthalmology & visual science.

[44]  Herbert Jägle,et al.  Reorganization of human cortical maps caused by inherited photoreceptor abnormalities , 2002, Nature Neuroscience.

[45]  S. Jacobson,et al.  CNGA3 mutations in hereditary cone photoreceptor disorders. , 2001, American journal of human genetics.

[46]  Jean Bennett,et al.  Gene therapy restores vision in a canine model of childhood blindness , 2001, Nature Genetics.

[47]  M. Naash,et al.  The relationship between opsin overexpression and photoreceptor degeneration. , 2001, Investigative ophthalmology & visual science.

[48]  M. Antoch,et al.  The Murine Cone Photoreceptor A Single Cone Type Expresses Both S and M Opsins with Retinal Spatial Patterning , 2000, Neuron.

[49]  P. Sieving,et al.  Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. , 2000, Human molecular genetics.

[50]  H. Wässle,et al.  Cloning and immunocytochemical localization of a cyclic nucleotide–gated channel α‐subunit to all cone photoreceptors in the mouse retina , 2000, The Journal of comparative neurology.

[51]  M. Biel,et al.  Molecular Cloning and Functional Characterization of a New Modulatory Cyclic Nucleotide-Gated Channel Subunit from Mouse Retina , 2000, The Journal of Neuroscience.

[52]  M. Seeliger,et al.  Selective loss of cone function in mice lacking the cyclic nucleotide-gated channel CNG3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Jacobson,et al.  Total colourblindness is caused by mutations in the gene encoding the α-subunit of the cone photoreceptor cGMP-gated cation channel , 1998, Nature Genetics.

[54]  J. Nathans,et al.  Blue cones and cone bipolar cells share transcriptional specificity as determined by expression of human blue visual pigment-derived transgenes , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  Donald J. Zack,et al.  A locus control region adjacent to the human red and green visual pigment genes , 1992, Neuron.

[56]  W. Bönigk,et al.  Primary structure and functional expression from complementary DNA of the rod photoreceptor cyclic GMP-gated channel , 1989, Nature.

[57]  C. Walker.  Ophthalmology , 1859, Bristol medico-chirurgical journal.

[58]  A. Swaroop,et al.  Transgenic Mice Expressing Cre-recombinase Specifically in M-or S-cone Photoreceptors and Anand Swaroop Materials and Methods , 2022 .

[59]  S. Siegelbaum,et al.  Structure and function of cyclic nucleotide-gated channels. , 1996, Annual review of neuroscience.